LobbyingBonumose lobbying by quarter
Bonumose's latest lobbying report covers Q1 2023, at $30K. Its first report covers Q4 2022; the issues it reports most are Health Issues.
Bonumose
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $45K | 1 |
| Q1 2023 | $30K | 1 |
| Q2 2023 | $0 | 0 |
| Q3 2023 | $0 | 0 |
| Q4 2023 | $0 | 0 |
| Q1 2024 | $0 | 0 |
| Q2 2024 | $0 | 0 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$75K · 2 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Food & Drug Administration (FDA)2 reports
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Foley & Lardner | $75K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JENNIFER FITZGERALD WALSH | AA; Deputy COS, COS: Rep. Dennis Cardoza; FieldRepresentative: Rep. Vic Fazio; Staff Asst, Program Dir, EA:House Democratic Caucus | Q1 2023 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 23/04/20for Q1 2023 | Foley & Lardner | $30K |
| 23/04/20for Q1 2023 | Foley & Lardner | $30K |
| 23/01/20for Q4 2022 | Foley & Lardner | $45K |